Formulation and Evaluation of Aerosolized Celecoxib for the Treatment of Lung Cancer

Author： Haynes Alfred Shaik Madhu Sudhan Chatterjee Abhijit Singh M.

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.22, Iss.3, 2005-03, pp. : 427-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of An Aerosolized Selective COX-2 Inhibitor as a Potentiator of Doxorubicin in a Non-Small-Cell Lung Cancer Cell Line

By Haynes Alfred Shaik Madhu Sudhan Chatterjee Abhijit Singh M.

Pharmaceutical Research, Vol. 20, Iss. 9, 2003-09 ,pp. : 1485-1495

Springer Publishing Company

Access to resources Recommend Favorite

Design, Development and Evaluation of Celecoxib-Loaded Microsponge-Based Topical Gel Formulation

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 3, Iss. 1, 2016-04 ,pp. : 44-55

Bentham Science Publishers

Access to resources Recommend Favorite

An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer

By Scagliotti Giorgio

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2855-2866

Informa Healthcare

Access to resources Recommend Favorite

Vandetanib for the treatment of lung cancer

By Chu Caleb T Sada Yvonne H Kim Edward S

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 8, 2012-08 ,pp. : 1211-1221

Informa Healthcare

Access to resources Recommend Favorite

Inhaled Formulation Design for the Treatment of Lung Infections

Current Pharmaceutical Design, Vol. 21, Iss. 27, 2015-01 ,pp. : 3875-3901

Bentham Science Publishers

Access to resources Recommend Favorite